Rubric Capital Management LP - Dec 13, 2021 Form 4 Insider Report for Radius Health, Inc. (RDUS)

Role
10%+ Owner
Signature
Rubric Capital Management LP, By: /s/ Michael Nachmani, its Chief Operating Officer
Stock symbol
RDUS
Transactions as of
Dec 13, 2021
Transactions value $
$3,191,376
Form type
4
Date filed
12/15/2021, 04:22 PM
Previous filing
Dec 10, 2021
Next filing
Dec 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RDUS Common Stock, par value $0.0001 per share ("Common Stock") Purchase $1.33M +187K +2.95% $7.08 6.54M Dec 13, 2021 See footnote F1, F2
transaction RDUS Common Stock Purchase $641K +94.1K +1.44% $6.81 6.63M Dec 14, 2021 See footnote F2, F3
transaction RDUS Common Stock Purchase $1.22M +181K +2.73% $6.77 6.81M Dec 15, 2021 See footnote F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.905 to $7.35, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
F2 This Form 4 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital. The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.71 to $7.03, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.59 to $6.98, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.